Comparison of response and toxicity of capecitabine and oxaliplatin chemotherapy regimen with taxol and carboplatin with radiotherapy in esophageal cancer patients

Phase 2

Recruiting

• Conditions: Chemoradiotherapy in esophageal cancer patients.; Malignant neoplasm of esophagus

• Registration Number: IRCT20170306032913N4
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 February 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Proper Performance Status.
No severe dysphagia

Exclusion Criteria

Age over 80.
Cervical Esophageal involvement

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pathologic and clinical response to chemoradiotherapy with two different regimens in esophageal cancer patients. Timepoint: Evaluation of response rate after completion of chemoradiotherapy and evaluation and comparison of complications during treatment. Method of measurement: Postoperative pathology report. EUS re-report after chemoradiotherapy.